Amphetamine, past and present – a pharmacological and clinical perspectiveDavid J. Heal, David Nutt, Jane Gosden et al.|Journal of Psychopharmacology|2013Cited by 614
Regulatory challenges for new drugs to treat obesity and comorbid metabolic disordersDavid J. Heal, Sharon L. Smith, Jane Gosden|British Journal of Clinical Pharmacology|2009Cited by 87
Mediation of the antidepressant‐like effect of 8‐OH‐DPAT in mice by postsynaptic 5‐HT<sub>1A</sub> receptorsGraham P. Luscombe, David J. Heal, Jane Gosden et al.|British Journal of Pharmacology|1993Cited by 87
Lisdexamfetamine and immediate release d-amfetamine – Differences in pharmacokinetic/pharmacodynamic relationships revealed by striatal microdialysis in freely-moving rats with simultaneous determination of plasma drug concentrations and locomotor activityHelen L. Rowley, David J. Heal, David P. Hackett et al.|Neuropharmacology|2012Cited by 65